シングルセルオミクス：新たな技術と市場

世界のシングルセルゲノミクスおよびプロテオミクスの市場規模は、2024年の40億米ドルから、予測期間中は17.6%のCAGRで推移し、2029年末には91億米ドルに達すると予測されています。

北米市場は、2024年の19億米ドルから、予測期間中は17.8%のCAGRで推移し、2029年末には43億米ドルに達すると予測されています。アジア太平洋地域は、2024年の8億8,720万米ドルから、18.1%のCAGRで推移し、2029年末には20億米ドルに達すると予測されています。

当レポートでは、世界のシングルセルオミクスの市場を調査し、市場概要、市場影響因子および市場機会の分析、法規制環境、新興技術および技術開発の動向、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

• 市場見通し
• 調査範囲
• 市場サマリー

第2章 市場概要

• 概要
• 技術的背景
• オミクスの種類
• 技術インフラとデータ統合
• マクロ経済要因分析
• 進行中のロシア・ウクライナ戦争がシングルセルゲノミクスおよびプロテオミクス市場に与える影響
• 経済の不確実性と研究資金の削減
• 運用コストの増加
• 地政学的協力の変化
• ロシアと技術輸出に対する制裁
• ポーターのファイブフォース分析

第3章 規制状況

• 規制の概要
• 国・地域別の市場規制
• 連邦規制
• CMS規制
• FDA規制
• FTC規制
• カナダ
• EU
• 英国
• 中国
• 日本
• オーストラリア
• 国際基準とガイドライン

第4章 市場力学

• 市場力学
• 市場促進要因
• シングルセルゲノミクスおよびプロテオミクスの研究活動への投資と資金の増加
• 癌罹患率の増加による個別化治療への需要の増加
• 医薬品開発プロセスにおけるシングルセルゲノミクスとプロテオミクスの有望な応用
• 市場抑制要因
• シングルセルプロテオミクスに伴う高コスト
• 技術的課題
• 市場機会
• シングルセル研究における技術の進歩と自動化
• コラボレーションとパートナーシップ

第5章 新興技術と開発

• シングルセルゲノミクスおよびプロテオミクスにおけるAI
• AIシングルセルゲノミクスおよびプロテオミクス市場の企業
• シングルセルオミクスとマルチオミクスの進歩

第6章 市場セグメンテーション分析

• 市場概要
• セグメンテーションの内訳
• 世界のシングルセルゲノミクスおよびプロテオミクス市場：分析タイプ別
• シングルセルゲノミクス
• シングルセルプロテオミクス
• シングルセルトランスクリプトミクス
• シングルセルエピゲノミクス
• 世界のシングルセルゲノミクスおよびプロテオミクス市場：用途別
• 腫瘍
• 幹細胞バイオロジー
• 免疫
• その他
• 世界のシングルセルゲノミクスおよびプロテオミクス市場：エンドユーザー別
• 学術研究機関
• バイオ医薬品およびバイオテクノロジー企業
• 臨床ラボ
• 応用市場
• 地理的内訳
• シングルセルゲノミクスおよびプロテオミクス市場：地域別
• 北米
• 欧州
• アジア太平洋
• その他の地域

第7章 競合情報

• 概要
• 主要企業ランキング
• 企業が採用した主要戦略
• コラボレーションとパートナーシップ
• 新製品の発売
• 拡張と投資
• M&A
• 特許分析
• サマリー

第8章 ゲノミクス・プロテオミクス市場における持続可能性：ESGの観点

• ESGイントロダクション
• 市場におけるESGパフォーマンス
• ゲノミクスおよびプロテオミクス業界におけるESG実践
• 環境パフォーマンス
• 社会的パフォーマンス
• ガバナンスパフォーマンス
• ESGリスク評価
• BCCによる総論

第9章 付録

• 調査手法
• 略語
• 企業プロファイル
• 10X GENOMICS
• AGILENT TECHNOLOGIES INC.
• BD
• BIO-RAD LABORATORIES INC.
• BIO-TECHNE
• BRUKER
• F. HOFFMANN-LA ROCHE LTD.
• ILLUMINA INC.
• MERCK KGAA
• PROMEGA CORP.
• QIAGEN
• SARTORIUS AG
• STANDARD BIOTOOLS
• TECAN TRADING AG
• THERMO FISHER SCIENTIFIC INC.

List of Tables

• Summary Table : Global Single-cell Genomics and Proteomics Market, by Region, Through 2029
• Table 1 : Molecular Biology Technologies for Multi-omics Approaches
• Table 2 : Single-cell and Spatial Omics Technologies, 2018-2023
• Table 3 : Companies in the AI Single-cell Genomics and Proteomics Market
• Table 4 : Global Single-cell Genomics and Proteomics Market, by Analysis Type, Through 2029
• Table 5 : Global Single-cell Genomics Market, by Region, Through 2029
• Table 6 : Global Single-cell Proteomics Market, by Region, Through 2029
• Table 7 : Global Single-cell Transcriptomics Market, by Region, Through 2029
• Table 8 : Global Single-cell Epigenomics Market, by Region, Through 2029
• Table 9 : Global Single-cell Genomics and Proteomics Market, by Application, Through 2029
• Table 10 : Global Single-cell Genomics and Proteomics Market for Oncology, by Region, Through 2029
• Table 11 : Global Single-cell Genomics and Proteomics Market for Stem Cell Biology, by Region, Through 2029
• Table 12 : Global Single-cell Genomics and Proteomics Market for Immunology, by Region, Through 2029
• Table 13 : Global Single-cell Genomics and Proteomics Market for Other Applications, by Region, Through 2029
• Table 14 : Global Single-cell Genomics and Proteomics Market, by End User, Through 2029
• Table 15 : Global Single-cell Genomics and Proteomics Market for Academic and Research Organizations, by Region, Through 2029
• Table 16 : Global Single-cell Genomics and Proteomics Market for Biopharmaceutical and Biotechnology Companies, by Region, Through 2029
• Table 17 : Global Single-cell Genomics and Proteomics Market for Clinical Laboratories, by Region, Through 2029
• Table 18 : Global Single-cell Genomics and Proteomics Market for Applied Markets, by Region, Through 2029
• Table 19 : Global Single-cell Genomics and Proteomics Market, by Region, Through 2029
• Table 20 : North American Genomics and Proteomics Market, by Analysis Type, Through 2029
• Table 21 : North American Genomics and Proteomics Market, by Application, Through 2029
• Table 22 : North American Genomics and Proteomics Market, by End User, Through 2029
• Table 23 : European Genomics and Proteomics Market, by Analysis Type, Through 2029
• Table 24 : European Genomics and Proteomics Market, by Application, Through 2029
• Table 25 : European Genomics and Proteomics Market, by End User, Through 2029
• Table 26 : Asia-Pacific Genomics and Proteomics Market, by Analysis Type, Through 2029
• Table 27 : Asia-Pacific Genomics and Proteomics Market, by Application, Through 2029
• Table 28 : Asia-Pacific Genomics and Proteomics Market, by End User, Through 2029
• Table 29 : RoW Genomics and Proteomics Market, by Analysis Type, Through 2029
• Table 30 : RoW Genomics and Proteomics Market, by Application, Through 2029
• Table 31 : RoW Genomics and Proteomics Market, by End User, Through 2029
• Table 32 : Top Players in the Single-cell Genomics and Proteomics Market, 2023
• Table 33 : Collaborations and Partnerships: Single-cell Genomics and Proteomics Market, 2021-2024
• Table 34 : New Product Launch: Single-cell Genomics and Proteomics Market, 2021-2024
• Table 35 : Expansions and Investments: Single-cell Genomics and Proteomics Market, 2021-2024
• Table 36 : Mergers and Acquisitions: Single-cell Genomics and Proteomics Market, 2020-2024
• Table 37 : Single-cell Genomics and Proteomics Market: Patent Analysis, 2018-2024
• Table 38 : Key Focus Areas in ESG Metrics
• Table 39 : Environmental Performance Initiatives in the Genomics and Proteomics Market
• Table 40 : Social Performance Initiatives in the Genomics and Proteomics Market
• Table 41 : Governance Performance Initiatives in the Genomics and Proteomics Market
• Table 42 : ESG Rankings for Genomics and Proteomics Companies, 2024*
• Table 43 : Abbreviations Used in this Report
• Table 44 : 10x Genomics: Company Snapshot
• Table 45 : 10x Genomics: Financial Performance, FY 2022 and 2023
• Table 46 : 10x Genomics: Product Portfolio
• Table 47 : 10x Genomics: News/Key Developments, 2024
• Table 48 : Agilent Technologies Inc.: Company Snapshot
• Table 49 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
• Table 50 : Agilent Technologies Inc.: Product Portfolio
• Table 51 : Agilent Technologies Inc.: News/Key Developments, 2023
• Table 52 : BD: Company Snapshot
• Table 53 : BD: Financial Performance, FY 2023 and 2024
• Table 54 : BD: Product Portfolio
• Table 55 : BD: News/Key Developments, 2023-2024
• Table 56 : Bio-Rad Laboratories Inc.: Company Snapshot
• Table 57 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
• Table 58 : Bio-Rad Laboratories Inc.: Product Portfolio
• Table 59 : Bio-Rad Laboratories Inc.: News/Key Developments, 2024
• Table 60 : Bio-Techne: Company Snapshot
• Table 61 : Bio-Techne: Financial Performance, FY 2022 and 2023
• Table 62 : Bio-Techne: Product Portfolio
• Table 63 : Bio-Techne: News/Key Developments, 2022
• Table 64 : Bruker: Company Snapshot
• Table 65 : Bruker: Financial Performance, FY 2022 and 2023
• Table 66 : Bruker: Product Portfolio
• Table 67 : Bruker: News/Key Developments, 2024
• Table 68 : F. Hoffmann-La Roche Ltd.: Company Snapshot
• Table 69 : F. Hoffman-La Roche Ltd.: Financial Performance, FY 2022 and 2023
• Table 70 : F. Hoffman-La Roche Ltd.: Product Portfolio
• Table 71 : F. Hoffman-La Roche Ltd.: News/Key Developments, 2021-2022
• Table 72 : Illumina Inc.: Company Snapshot
• Table 73 : Illumina Inc.: Financial Performance, FY 2022 and 2023
• Table 74 : Illumina Inc.: Product Portfolio
• Table 75 : Illumina Inc.: News/Key Developments, 2022-2023
• Table 76 : Merck KGaA: Company Snapshot
• Table 77 : Merck KGaA: Financial Performance, FY 2022 and 2023
• Table 78 : Merck KGaA: Product Portfolio
• Table 79 : Promega Corp.: Company Snapshot
• Table 80 : Promega Corp.: Product Portfolio
• Table 81 : Promega Corp.: News/Key Developments, 2022-2023
• Table 82 : Qiagen: Company Snapshot
• Table 83 : Qiagen: Financial Performance, FY 2022 and 2023
• Table 84 : Qiagen: Product Portfolio
• Table 85 : Qiagen: News/Key Developments, 2022-2024
• Table 86 : Sartorius AG: Company Snapshot
• Table 87 : Sartorius AG: Financial Performance, FY 2022 and 2023
• Table 88 : Sartorius AG: Product Portfolio
• Table 89 : Sartorius AG: News/Key Developments, 2024
• Table 90 : Standard BioTools: Company Snapshot
• Table 91 : Standard BioTools: Financial Performance, FY 2022 and 2023
• Table 92 : Standard BioTools: Product Portfolio
• Table 93 : Standard BioTools: News/Key Developments, 2022-2024
• Table 94 : Tecan Trading AG: Company Snapshot
• Table 95 : Tecan Trading AG: Financial Performance, FY 2022 and 2023
• Table 96 : Tecan Trading AG: Product Portfolio
• Table 97 : Tecan Trading AG: News/Key Developments, 2024
• Table 98 : Thermo Fisher Scientific Inc.: Company Snapshot
• Table 99 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
• Table 100 : Thermo Fisher Scientific Inc.: Product Portfolio
• Table 101 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022-2024

List of Figures

• Summary Figure : Global Single-cell Genomics and Proteomics Market Share, by Region, 2023
• Figure 1 : Types of Omics
• Figure 2 : Porter's Five Forces Analysis for the Single-cell Genomics and Proteomics Market
• Figure 3 : Market Dynamics of Single-cell Genomics and Proteomics
• Figure 4 : Global Single-cell Genomics and Proteomics Market Share, by Analysis Type, 2023
• Figure 5 : Global Single-cell Genomics Market Share, by Region, 2023
• Figure 6 : Global Single-cell Proteomics Market Share, by Region, 2023
• Figure 7 : Global Single-cell Transcriptomics Market Share, by Region, 2023
• Figure 8 : Global Single-cell Epigenomics Market Share, by Region, 2023
• Figure 9 : Global Single-cell Genomics and Proteomics Market Share, by Application, 2023
• Figure 10 : Global Single-cell Genomics and Proteomics Market Share, by End User, 2023
• Figure 11 : Global Single-cell Genomics and Proteomics Market Share, by Region, 2023
• Figure 12 : North American Single-cell Genomics and Proteomics Market Share, by Analysis Type, 2023
• Figure 13 : European Single-cell Genomics and Proteomics Market Share, by Analysis Type, 2023
• Figure 14 : Asia-Pacific Single-cell Genomics and Proteomics Market Share, by Analysis Type, 2023
• Figure 15 : RoW Single-cell Genomics and Proteomics Market Share, by Analysis Type, 2023
• Figure 16 : Snapshot of ESG Pillars
• Figure 17 : Advantages of ESG for Companies
• Figure 18 : Share of Biotech Companies Providing ESG Disclosure, 2022
• Figure 19 : Share of ESG Disclosure Location for the Biotech Companies, 2022
• Figure 20 : 10x Genomics: Revenue Share, by Business Unit, FY 2023
• Figure 21 : 10x Genomics: Revenue Share, by Country/Region, FY 2023
• Figure 22 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
• Figure 23 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
• Figure 24 : BD: Revenue Share, by Business Unit, FY 2024
• Figure 25 : BD: Revenue Share, by Country/Region, FY 2024
• Figure 26 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
• Figure 27 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
• Figure 28 : Bio-Techne: Revenue Share, by Business Unit, FY 2023
• Figure 29 : Bio-Techne: Revenue Share, by Country/Region, FY 2023
• Figure 30 : Bruker: Revenue Share, by Business Unit, FY 2023
• Figure 31 : Bruker: Revenue Share, by Country/Region, FY 2023
• Figure 32 : F. Hoffman-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
• Figure 33 : F. Hoffman-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
• Figure 34 : Illumina Inc.: Revenue Share, by Business Unit, FY 2023
• Figure 35 : Illumina Inc.: Revenue Share, by Country/Region, FY 2023
• Figure 36 : Merck KGaA: Revenue Share, by Business Unit, FY 2023
• Figure 37 : Merck KGaA: Revenue Share, by Country/Region, FY 2023
• Figure 38 : Qiagen: Revenue Share, by Business Unit, FY 2023
• Figure 39 : Qiagen: Revenue Share, by Country/Region, FY 2023
• Figure 40 : Sartorius AG: Revenue Share, by Business Unit, FY 2023
• Figure 41 : Sartorius AG: Revenue Share, by Country/Region, FY 2023
• Figure 42 : Standard BioTools: Revenue Share, by Business Unit, FY 2023
• Figure 43 : Standard BioTools: Revenue Share, by Country/Region, FY 2023
• Figure 44 : Tecan Trading AG: Revenue Share, by Business Unit, FY 2023
• Figure 45 : Tecan Trading AG: Revenue Share, by Country/Region, FY 2023
• Figure 46 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
• Figure 47 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023

The global market for single-cell genomics and proteomics is expected to grow from $4.0 billion in 2024 to reach $9.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 17.6% from 2024 through 2029.

The North American market for single-cell genomics and proteomics is expected to grow from $1.9 billion in 2024 to reach $4.3 billion by the end of 2029, at a CAGR of 17.8% from 2024 through 2029.

The Asia-Pacific market for single-cell genomics and proteomics is expected to grow from $887.2 million in 2024 to reach $2.0 billion by the end of 2029, at a CAGR of 18.1% from 2024 through 2029.

Report Scope:

The report highlights the current and future market potential of single-cell genomics and proteomics and a detailed analysis of the market drivers, restraints and opportunities. The report also covers market projections for 2029, including a competitive environment and product analysis. The report provides market estimates and forecasts for single-cell genomics and proteomics based on analysis type, application, end user and region. Based on product type, the market is segmented into single-cell genomics, single-cell epigenomics and single-cell transcriptomics. The market is categorized as academic and research organizations, biopharmaceutical and biotechnology companies, and applied markets and clinical laboratories based on end user. The market is segmented into stem cell biology, oncology, immunology, microbiology and others based on application.

The report includes the company profiles of the key players with detailed information about their business segments, financials, product portfolios and recent developments. By geography, the market has been organized into North America, Europe, Asia-Pacific and the Rest of the World (RoW). The North American region includes countries such as the U.S., Canada and Mexico. Europe includes Germany, the UK, Italy, France, Spain and the rest of Europe; Asia-Pacific includes countries such as China, Japan, India, Australia, South Korea and the rest of Asia-Pacific. The Rest of the World includes South America and the Middle East and Africa. For market estimates, data has been provided for 2021 and 2022 as the historic years, 2023 as the base year, and forecast for 2029.

Report Includes:

• 43 data tables and 59 additional tables
• An overview of the global markets and emerging technologies for single-cell genomics and proteomics
• Analyses of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
• Evaluation of and forecast for the overall market for single-cell genomics and proteomics, and quantification of the market potential by analysis type, application, end user and region
• Description of cell isolation technologies, including flow cytometry, laser capture microscopy and micromanipulation, and sample preparation technologies, including microfluidics and whole genome amplification/pre-amplification
• Coverage of NGS, qPCR/PCR, microarrays, mass spectrometry and microfluidics
• Discussion of the major market dynamics and shifts, and the regulations, industry challenges, and macroeconomic factors that will affect the single-cell genomics and proteomics market over the coming years
• Review of the patent filings and research publications for innovations in single-cell genomics and proteomics technology
• A discussion of the industry's ESG challenges and practices
• Identification of the companies that are best positioned to meet this demand because of their proprietary technologies, strategic alliances, or other advantages
• Insight into industry structure, competitive landscape, clinical trials and ongoing research activity
• Profiles of the major players, including 10x Genomics, Thermo Fisher Scientific Inc., Illumina Inc., BD and Merck KGaA

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Technology Background
• Types of Omics
• Technological Infrastructure and Data Integration
• Macroeconomic Factors Analysis
• Impact of Ongoing Russia-Ukraine War on the Single-cell Genomics and Proteomics Market
• Economic Uncertainty and Research Funding Cuts
• Increased Operational Costs
• Shift in Geopolitical Collaborations
• Sanctions on Russia and Technology Exports
• Porter's Five Forces Analysis
• Bargaining Power of Buyers
• Bargaining Power of Suppliers
• Potential of New Entrants
• Competition in the Industry
• Threat of Substitutes

Chapter 3 Regulatory Landscape

• Regulatory Overview
• Market Regulations by Country/Region
• Federal Regulation
• CMS Regulation
• FDA Regulation
• FTC Regulation
• Canada
• European Union
• United Kingdom (U.K.)
• China
• Japan
• Australia
• International Standards and Guidelines

Chapter 4 Market Dynamics

• Market Dynamics
• Market Drivers
• Increasing Investment and Funding for Single-cell Genomics and Proteomics Research Activities
• Growing Prevalence of Cancer Generating Demand for Personalized Treatments
• Promising Applications of Single-cell Genomics and Proteomics in the Drug Development Process
• Market Restraints
• High Costs Associated with Single-cell Proteomics
• Technical Challenges
• Market Opportunities
• Technological Advances and Automation in Single-cell Studies
• Collaboration and Partnerships

Chapter 5 Emerging Technologies and Developments

• Artificial Intelligence in Single-cell Genomics and Proteomics
• Companies in the AI Single-cell Genomics and Proteomics Market
• Advances in Single-cell Omics and Multi-omics

Chapter 6 Market Segmentation Analysis

• Market Overview
• Segmentation Breakdown
• Global Single-cell Genomics and Proteomics Market by Analysis Type
• Single-cell Genomics
• Single-cell Proteomics
• Single-cell Transcriptomics
• Single-cell Epigenomics
• Global Single-cell Genomics and Proteomics Market by Application
• Oncology
• Stem Cell Biology
• Immunology
• Other Applications
• Global Single-cell Genomics and Proteomics Market by End User
• Academic and Research Organizations
• Biopharmaceutical and Biotechnology Companies
• Clinical Laboratories
• Applied Markets
• Geographic Breakdown
• Global Single-cell Genomics and Proteomics Market by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 7 Competitive Intelligence

• Overview
• Top Players Ranking
• Key Strategies Adopted by Players
• Collaborations and Partnerships
• New Product Launches
• Expansions and Investments
• Mergers and Acquisitions
• Patent Analysis
• Takeaways

Chapter 8 Sustainability in the Genomics and Proteomics Market: ESG Perspective

• Introduction to ESG
• ESG Performance in the Market
• ESG Practices in the Genomics and Proteomics Industry
• Environmental Performance
• Social Performance
• Governance Performance
• ESG Risk Ratings
• Concluding Remarks from BCC Research

Chapter 9 Appendix

• Methodology
• Abbreviations
• Company Profiles
• 10X GENOMICS
• AGILENT TECHNOLOGIES INC.
• BD
• BIO-RAD LABORATORIES INC.
• BIO-TECHNE
• BRUKER
• F. HOFFMANN-LA ROCHE LTD.
• ILLUMINA INC.
• MERCK KGAA
• PROMEGA CORP.
• QIAGEN
• SARTORIUS AG
• STANDARD BIOTOOLS
• TECAN TRADING AG
• THERMO FISHER SCIENTIFIC INC.